Intellipharmaceutics has recently filed an ANDA with the USFDA for Focalin XR® 30 mg strength. They have already filed ANDA for the same product for , 10, 15 and 20 mg strengths. This filing of 30 mg strength is an amendment to the previous filing. This ANDA is the fourth such filing by Intellipharmaceutics in the last year.
For details click here
No comments:
Post a Comment